Sign Up Today and Learn More About Kaspersky Lab Stock

Invest in or calculate the value of your shares in Kaspersky Lab or other pre-IPO companies through EquityZen's platform.

Get Started

Kaspersky Lab Stock

Endpoint protection solutions for consumers, SMBs and enterprises.

About Kaspersky Lab Stock



Kaspersky Lab is the world’s largest privately held vendor of endpoint protection solutions. The company is ranked among the world’s top four vendors of security solutions for endpoint users. It is an innovator in IT security and provides effective digital security solutions and threat management systems for consumers, SMBs and enterprises. The Kaspersky anti-virus engine also powers products and solutions by other security vendors such as Check Point, Bluecoat, Juniper Networks, Sybari, Netintelligence, Clearswift, FrontBridge, Netasq, Wedge Networks, and others. Kaspersky Lab is headquartered in Moscow, Russia, with 30 regional offices in Australia, Austria, Benelux, Brazil, Canada, Mainland China, France, Germany, Hong Kong, India, Italy, Taiwan, Japan, Kazakhstan, Korea, Latvia, Malaysia, Poland, Portugal, Romania, Russian Federation, South Africa, Spain, Sweden, Switzerland, Turkey, Ukraine, United Arab Emirates, United Kingdom, and the United States of America. It was co-founded by Eugene Kaspersky and Natalia Kaspersky in 1997. Kaspersky Lab has over 2,500 employees, including more than 800 research and development specialists, providing protection for over 300 million users worldwide.

Kaspersky Lab Management

Leadership team at Kaspersky Lab

Enterprise & Partner Pre-Sales Engineer

Mark Olding

Research Development Team Lead

Victor Chebyshev

Locked Features

Join now and verify your accreditation status to gain access to:

  • Kaspersky Lab current valuation
  • Kaspersky Lab stock price
  • Available deals in Kaspersky Lab and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Kaspersky Lab stock?

Accredited investors can buy pre-IPO stock in companies like Kaspersky Lab through EquityZen funds. These investments are made available by existing Kaspersky Lab shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Kaspersky Lab stock?

Shareholders can sell their Kaspersky Lab stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."